Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ·Healthcare·Biotechnology
$3.69
-9.14%
Mkt Cap $2.12B
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (8 analysts)
$5.50
Range $5.50 – $5.50
Implied Upside
+49.3%
Consensus $5.50 vs current $3.69
NASDAQ·Healthcare·Biotechnology
$3.69
-9.14%
Mkt Cap $2.12B
Buy
2
Hold
1
Sell
0
Price Target (8 analysts)
$5.50
Range $5.50 – $5.50
+49.3%
Consensus $5.50 vs current $3.69